UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Biochemical pharmacology, ISSN 0006-2952, 09/2017, Volume 139, pp. 40 - 55
Covalent mechanisms | Non-covalent mechanisms | Amyloid inhibitor | Natural products | Inhibition mechanisms | Amyloidosis - prevention & control | Drugs, Investigational - pharmacology | Antioxidants - chemistry | Nootropic Agents - metabolism | Antioxidants - metabolism | Healthy Diet | Humans | Polyphenols - pharmacology | Drugs, Investigational - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Biological Products - pharmacology | Flavonoids - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Polyphenols - metabolism | Amyloidogenic Proteins - antagonists & inhibitors | Drugs, Investigational - chemistry | Protein Aggregation, Pathological - prevention & control | Amyloidosis - diet therapy | Drug Design | Flavonoids - pharmacology | Protein Aggregation, Pathological - diet therapy | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Chelating Agents - therapeutic use | Biological Products - therapeutic use | Chelating Agents - chemistry | Nootropic Agents - therapeutic use | Amyloidosis - drug therapy | Antioxidants - pharmacology | Chelating Agents - pharmacology | Nootropic Agents - chemistry | Drug Discovery | Protein Aggregation, Pathological - drug therapy | Amyloidogenic Proteins - metabolism | Antioxidants - therapeutic use | Biological Products - chemistry | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Flavonoids - metabolism | Polyphenols - chemistry | Biological Products - metabolism | Polyphenols - therapeutic use | Chelating Agents - metabolism | Dietary Supplements | Flavonoids - chemistry | Amyloidosis - metabolism | Nootropic Agents - pharmacology | Medicine, Experimental | Medical research | Nervous system diseases | Glycoproteins | Drug discovery | Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 2/2008, Volume 51, Issue 3, pp. 347 - 372
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Neurology | Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Antioxidants - chemistry | Humans | Calcium Channel Blockers - therapeutic use | Cholinesterase Inhibitors - chemistry | Parkinson Disease - drug therapy | Neurodegenerative Diseases - drug therapy | Alzheimer Disease - pathology | Neurofibrillary Tangles - metabolism | Amyloid beta-Peptides - metabolism | Parkinson Disease - metabolism | Huntington Disease - drug therapy | Binding Sites | Chelating Agents - therapeutic use | Multiple Sclerosis - metabolism | Neurofibrillary Tangles - pathology | Neurodegenerative Diseases - pathology | Plaque, Amyloid - pathology | Chelating Agents - chemistry | Neurotransmitter Agents - metabolism | Alzheimer Disease - drug therapy | Antioxidants - pharmacology | Chelating Agents - pharmacology | Neurodegenerative Diseases - metabolism | Calcium Channel Blockers - pharmacology | Huntington Disease - metabolism | Antioxidants - therapeutic use | Cholinesterase Inhibitors - pharmacology | Alzheimer Disease - metabolism | Calcium Channel Blockers - chemistry | Ligands | Plaque, Amyloid - metabolism | Cholinesterase Inhibitors - therapeutic use | Acetylcholinesterase - metabolism | Multiple Sclerosis - drug therapy | Index Medicus
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 2019, Volume 26, Issue 2, pp. 302 - 322
Chelators | Iron | Copper and zinc | Metals | Anti-cancer drugs | Cancer | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Neoplasms - metabolism | Metals, Heavy - metabolism | Humans | Chelating Agents - chemistry | Antineoplastic Agents - therapeutic use | Chelating Agents - pharmacology | Antineoplastic Agents - chemistry | Neoplasms - drug therapy | Thiosemicarbazones - chemistry | Animals | Thiosemicarbazones - therapeutic use | Neoplasm Metastasis - prevention & control | Cell Line, Tumor | Ligands | Antineoplastic Agents - pharmacology | Thiosemicarbazones - pharmacology | Metals, Heavy - chemistry | Chelating Agents - therapeutic use | Drug Resistance, Neoplasm - drug effects | Binding | Cell proliferation | Medical research | Metal concentrations | Clinical trials | Homeostasis | Metabolism | Drug development | Biological activity | Metastases | Anticancer properties | Proteins | Cell growth | Antitumor agents | Chelating agents | Energy transduction | Tumors | Metal ions
Journal Article
Antioxidants & redox signaling, ISSN 1523-0864, 03/2013, Volume 18, Issue 8, pp. 973 - 1006
Forum Review Articles | Biochemistry & Molecular Biology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Neoplasms - metabolism | Iron Chelating Agents - therapeutic use | Humans | Chelating Agents - chemistry | Coordination Complexes - metabolism | Antineoplastic Agents - therapeutic use | Chelating Agents - pharmacology | Antineoplastic Agents - chemistry | Iron - metabolism | Iron Chelating Agents - chemistry | Neoplasms - drug therapy | Metals - metabolism | Animals | Iron Chelating Agents - pharmacology | Oxidation-Reduction - drug effects | Antineoplastic Agents - pharmacology | Chelating Agents - therapeutic use | Usage | Care and treatment | Forecasts and trends | Chelating agents | Cancer | Index Medicus
Journal Article